| |
|||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||
|
Clinical Diagnostics Fast, accurate and easy detection and identification of infectious pathogens is a vital decision-making tool for physicians. Taking this into account, TAAG® Diagnostics is creating and marketing molecular tests to be used in several areas of clinical diagnostics, for instance, Healthcare Acquired Infections (HAI), Respiratory Infectious Diseases (RID), Sexually Transmitted Diseases (STD), etc. TAAG® Diagnostics expects to continue with intense development of its portfolio of kits with the release of additional products in the areas of multiple pathogens identification, strain typing andgenetic disease.
|
|
|||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||